Note: Ingredients listed on restricted chemical lists
EC/CAS
200-431-6/59-50-7
Name of the chemical
Chlorocresol
Concentration
N/A
General Information
Version
2.2
Revision date
2023-08-11
Product name
Sedivet solution for injection
Product Synonyms
Sedivet® solution for injection 1.0%, Romifidine hydrochloride
1.2.1 Relevant identified uses
Veterinary product
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., For veteri- on use nary use only, Refer to the product insert for complete instruc- tions on usage
Emergency telephone
+498007790900, +1 703-527-3887, +49800 1817059
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H371
Hazard statements
Code
Statements
H371
May cause damage to organs
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning
Hazard statements
H371 May cause damage to organs (Cardio-vascular system, Central nervous system).
Prevention
P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this prod- uct.
Response
P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
1H-Imidazol-2-amine, N-(2-bromo-6-fluorophenyl)-4,5-dihydro-, monohydrochloride
Additional information
EUH208
Contains
4-chlorocresol. May produce an allergic reaction The following percentage of the mixture consists of ingredient(s) with unknown hazards to the aquatic environment: 1 %
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Specific target organ toxicity - single ex- H371: May cause damage to organs. posure, Category 2, Cardio-vascular sys- tem, Central nervous system
